BIO Chart
- 52-Week Range: $475.22 - $825.77
- Market Capitalization: $15.41B
- Short Percentage: 0%
- Target Price: $711.67
- Shares Outstanding: 24.88M
- Next Earnings: Feb 10
Catalysts
CategoryCatalyst
Earnings
BIO released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | April 28th
- Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022Business Wire | April 18th
- Bio-Rad Announces Closing of $1.2 Billion Aggregate Senior Notes OfferingBusiness Wire | March 2nd
- Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor DayBusiness Wire | February 25th
- Bio Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 10th
- Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022Business Wire | January 25th
- Bio-Rad Appoints Simon May Executive Vice President and Life Science Group PresidentBusiness Wire | December 16th
- Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | October 28th
Company Info
Website: https://www.bio-rad.com
Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
Sector: Healthcare
Industry: Medical Devices
Full time employees: 7,900
Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
Sector: Healthcare
Industry: Medical Devices
Full time employees: 7,900
$BIO what happen
$BIO still bullish
$BIO I’ll be buying more if this dips!
$BIO buy and hodl friends. we may be early
but we are not wrong. very soon.
$BIO i am trading for a better future!
$BIO going green
$BIO added!
$BIO keep it going
$BIO I like the stock!
$BIO let’s buy NOW!!!